由门静脉高压引起并伴有中枢性尿崩症的门肺高压。
Portopulmonary hypertension caused by portal hypertension that is complicated by central diabetes insipidus.
作者信息
Zhao Tingting, Xing Qian, Yang Xiaojuan, Yao Xiaofeng, Ba Ying, Zhou Haicheng, Liu Dan
机构信息
Department of Nephrology The First Affiliated Hospital of Dalian Medical University Dalian China.
Department of Endocrinology The First Affiliated Hospital of Dalian Medical University Dalian China.
出版信息
Clin Case Rep. 2020 Feb 11;8(3):520-522. doi: 10.1002/ccr3.2675. eCollection 2020 Mar.
Abstract
We discuss the pathophysiology, diagnosis, differential diagnosis, and therapy of a case with central diabetes insipidus, idiopathic portal hypertension, and portopulmonary hypertension. This report reviews how vasopressin affects those diseases.
摘要
我们讨论了一例中枢性尿崩症、特发性门静脉高压症和门肺高压症患者的病理生理学、诊断、鉴别诊断及治疗。本报告回顾了血管加压素如何影响这些疾病。
相似文献
1
Portopulmonary hypertension caused by portal hypertension that is complicated by central diabetes insipidus.由门静脉高压引起并伴有中枢性尿崩症的门肺高压。
Clin Case Rep. 2020 Feb 11;8(3):520-522. doi: 10.1002/ccr3.2675. eCollection 2020 Mar.
2
[Central diabetes insipidus: diagnostic difficulties].[中枢性尿崩症：诊断难题]
Ann Endocrinol (Paris). 2008 Jun;69(3):231-9. doi: 10.1016/j.ando.2007.11.003. Epub 2008 May 19.
3
Portopulmonary hypertension.门脉高压性肺高血压
J Clin Gastroenterol. 2011 Sep;45(8):703-10. doi: 10.1097/MCG.0b013e31820656bd.
4
Central Diabetes Insipidus in a Preterm Neonate Unresponsive to Intranasal Desmopressin.一名对鼻内去氨加压素无反应的早产儿的中枢性尿崩症
Neonatal Netw. 2020 Nov 1;39(6):339-346. doi: 10.1891/0730-0832/11-T-679.
5
Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey.从患者角度看中枢性尿崩症：管理、心理共病和疾病更名：国际网络调查结果。
Lancet Diabetes Endocrinol. 2022 Oct;10(10):700-709. doi: 10.1016/S2213-8587(22)00219-4. Epub 2022 Aug 22.
6
Diabetes insipidus: clinical and basic aspects.尿崩症：临床与基础方面
Pediatr Endocrinol Rev. 2006 Dec;4 Suppl 1:60-5.
7
Diabetes insipidus in pregnancy: etiology, evaluation, and management.妊娠期间的尿崩症：病因、评估及管理
Endocr Pract. 2009 May-Jun;15(4):377-82. doi: 10.4158/EP09090.RA.
8
Portopulmonary hypertension: Success with combined medical treatment.门肺高压：联合药物治疗取得成功
Respirol Case Rep. 2023 Mar 16;11(4):e01114. doi: 10.1002/rcr2.1114. eCollection 2023 Apr.
9
10
Sudden Vasopressin Withdrawal Causing Transient Central Diabetes Insipidus: A Case Report.突然停用血管加压素导致短暂性中枢性尿崩症：一例报告
Cureus. 2022 May 13;14(5):e24966. doi: 10.7759/cureus.24966. eCollection 2022 May.
本文引用的文献
1
The Changing Role of Sodium Management in Cirrhosis.肝硬化中钠管理的角色转变
Curr Treat Options Gastroenterol. 2016 Jun;14(2):274-84. doi: 10.1007/s11938-016-0094-y.
2
Pulmonary Langerhans cell histiocytosis: a comprehensive analysis of 40 patients and literature review.肺朗格汉斯细胞组织细胞增生症：40 例患者的综合分析及文献复习。
Eur J Intern Med. 2015 Jun;26(5):351-6. doi: 10.1016/j.ejim.2015.04.001. Epub 2015 Apr 17.
3
"Porto-pulmonary hypertension: a comprehensive review".门静脉高压性肺动脉高压：综述
Clin Res Hepatol Gastroenterol. 2015 Apr;39(2):157-67. doi: 10.1016/j.clinre.2014.12.011. Epub 2015 Feb 7.
4
The effect of vasopressin and related compounds at V1a and V2 receptors in animal models relevant to human disease.血管加压素及相关化合物在与人类疾病相关的动物模型中对V1a和V2受体的作用。
Basic Clin Pharmacol Toxicol. 2006 Aug;99(2):96-103. doi: 10.1111/j.1742-7843.2006.pto_299.x.
5
Desmopressin (DDAVP) induces NO production in human endothelial cells via V2 receptor- and cAMP-mediated signaling.去氨加压素（DDAVP）通过V2受体和环磷酸腺苷（cAMP）介导的信号传导诱导人内皮细胞产生一氧化氮（NO）。
J Thromb Haemost. 2003 Apr;1(4):821-8. doi: 10.1046/j.1538-7836.2003.00197.x.
6
Desmopressin is a potent vasorelaxant of aorta and pulmonary artery isolated from rabbit and rat.去氨加压素是从兔和大鼠分离出的主动脉和肺动脉的强效血管舒张剂。
Anesthesiology. 1990 May;72(5):858-64. doi: 10.1097/00000542-199005000-00016.
Zotero 插件